Physician profile
Rajesh Arakal
NPI 1124197827
$79,409.31
in general payments reported to CMS, 2019-2025
11 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $7,296 · 2021: $3,204 · 2022: $15K · 2023: $10K · 2024: $15K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Travel and Lodging: $5,693 · Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,890.00 |
| Travel and Lodging | $5,693.48 |
| Food and Beverage | $1,761.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $77,206.17 | 2019-2025 | Conduit, Viper, Expedium |
| Depuy Synthes Sales INC. | $917.70 | 2020-2025 | Expedium, Expedium Verse, Conduit |
| Globus Medical, INC. | $916.29 | 2024-2025 | Fortify, Senza, Acp |
| Carlsmed, INC. | $162.88 | 2021 | |
| Smith+Nephew, INC. | $116.52 | 2019 | |
| Boston Scientific Corporation | $30.55 | 2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $21.38 | 2023 | Eterna |
| Edwards Lifesciences Corporation | $14.86 | 2024 | Hemosphere |
| Medline Industries LP | $13.78 | 2019 | |
| Lifenet Health | $9.18 | 2025 | Pliafx Flo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Arakal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.